Experts Talk Current and Emerging Therapies for Myelofibrosis

By Prithviraj Bose, MD, Andrew Kuykendall, MD, Lucia Masarova, MD, Francesca Palandri, MD, PhD - Last Updated: February 6, 2025

Prithviraj Bose, MD, of MD Anderson Cancer Center, Francesca Palandri, MD, PhD, of Università di Bologna, Andrew Kuykendall, MD, of Moffitt Cancer Center, and Lucia Masarova, MD, of MD Anderson Cancer Center discuss the current treatment landscape for myelofibrosis. These renowned experts share their perspectives on emerging therapies, clinical challenges, and advancements in managing this complex condition.

Advertisement

Post Tags:ASH 2024: MF
Advertisement
Advertisement
Advertisement